NCT04081610View on ClinicalTrials.gov

Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

October 23, 2019

Study Completion Date

November 13, 2019

Conditions
Dry Eye
Interventions
DRUG

lagricel ofteno multidose

"* Dosage: 1 drop 4 times a day per 7 days, both eyes~* Route of administration: Ophthalmic"

DRUG

lagricel ofteno single dose

"* Dosage: 1 drop 4 times a day per 7 days, both eyes~* Route of administration: Ophthalmic"

Trial Locations (1)

45070

Biomedical research G & LS de RL de CV, Guadalajara

All Listed Sponsors
lead

Laboratorios Sophia S.A de C.V.

INDUSTRY

NCT04081610 - Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution | Biotech Hunter | Biotech Hunter